Paying attention to those changesand adjusting accordinglyis what tends to matter most
doi: 10.1038/s42255-024-01113-9 29 Pi-SunyerXAstrupAFujiokaKGreenwayFHalpernAKrempfMet al
Chronic icv Ex-4 lowered blood glucose levels during the first 4 days of treatment and glucose levels remained depressed throughout the duration of the treatment period (see Supplementary material online, Figure S3B )
doi: 10.3390/jcm12010145 Summary Keywords type 2 diabetes, chronic kidney disease, GLP-1 receptor agonists, semaglutide, glycosylated hemoglobin, weight loss, estimated glomerular filtration rate, urinary albumin-to-creatinine ratio Citation Garca de Lucas MD, Caballero I, Fernndez-Garca JC, Domnguez-Rodrguez M, Moreno-Moreno P, Jimnez-Milln A, Botana-Lpez M, Avils B, Merino-Torres JF, Soto A, Tejera C and Morales C (2023) Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study
The Cochrane Collaboration (2008)
The speed is impressive, but the duration is short, and phase 2 is not phase 3
